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Background
Aortic valve replacement (AVR) is the definitive treat-
ment for severe symptomatic aortic stenosis (AS). Aortic
stenosis is associated with diastolic dysfunction and left
atrial (LA) enlargement. After a successful AVR, there is
a decrease in LA size but persistence in diatolic dysfunc-
tion. We hypothesized that LA function would help link
this discordance. Cardiac magnetic resonance (CMR) is
the gold standard for assessment of the LA. We there-
fore aimed to test the effect of AS on LA function and
the subsequent effects of an AVR on LA function. We
hypothesized that, similar to diastolic function, LA func-
tion would not improve post-AVR and that the persis-
tence in LA dysfunction might be related to expansion
of the extracellular space.
Methods
A comprehensive CMR exam was performed on 18
patients with isolated AS and without coronary disease
pre- and 1 year post-AVR. Results were compared to
age- and gender matched healthy controls. Left atrial
volumes (LAV) were calculated at the end of ventricular
systole (LAVmax), just before atrial contraction (LAV-
bac), and at the end of ventricular diastole (LAVmin)
using the biplane area-length method. Left atrial passive
emptying fraction (LAPEF) defined by (LAVmax-LAV-
bac) × 100/LAVmax, as well as left atrial contractile
emptying fraction (LACEF) defined by (LAVbac-LAV-
min) × 100/LAVbac were calculated. T1 measurements
were made in the myocardium and blood before and
after contrast administration using a Look-Locker
sequence with a gradient echo cine acquisition. The
ECV was calculated by comparing the change in the R1
values from blood to myocardium and integrating the
hematocrit.
Results
Patients were predominantly male (67%) with a mean
age of 61 ± 12 years, and a mean LVEF of 62 ± 5%.
Prior to AVR, patients with AS had an increased left
ventricular (LV) mass, increased LA volume, reduced
LAPEF, and an increased ECV (Table 1). At one year
after AVR, there was a marked reduction in LV mass
and a decrease in LA volume. However, there was
further impairment in LAPEF and a continued increase
in the ECV at 1 year post-AVR (Table, Graph). There
was a strong inverse association between the LAPEF
and the ECV (r = -0.70, p < 0.001) and a strong inverse
association between the decline in LAPEF and the
increase in the ECV post AVR (r = -0.71, p < 0.001).
Conclusions
Severe AS is associated with a reduction in LA passive
function. After AVR, LAPEF continues to decline and
there was a strong inverse association between LAPEF
and the ECV.
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Variable Healthy
Controls
(N = 6)*
AS Pre-AVR
(N = 18)* **
AS Post-AVR
(N = 18) **
P-value,
ANOVA
*P-value, Healthy
Controls
vs. AS Pre-AVR
**P-value, AS
Pre-AVR vs. AS
Post-AVR
Age (years) 60 ± 8 60 ± 11 62 ± 10 0.91 1.00 0.29
Male (%) 66.67 66.67 66.67 1.00 1.00 1.00
Systolic Blood Pressure
(mmHg)
120 ± 4 123 ± 9 134 ± 12 0.001 0.56 0.0004
Diastolic Blood Pressure
(mmHg)
74 ± 7 79 ± 8 76 ± 12 0.38 0.17 0.16
Heart rate (beats/min) 72 ± 12 68 ± 10 68 ± 10 0.61 0.35 0.85
BMI (kg/m2) 25 ± 6 28 ± 6 28 ± 6 0.55 0.26 0.16
Cardiac Magnetic Resonance:
LV EF (%) 64 ± 5 67 ± 7 61 ± 5 0.01 0.21 0.005
LVEDV (mls) 123 ± 21 147 ± 38 132 ± 25 0.19 0.14 0.03
LVESV (mls) 43 ± 13 49 ± 19 51 ± 13 0.72 0.65 0.6
LV mass index (g/m2) 47 ± 5 72 ± 12 60 ± 8 <0.001 <0.0001 0.0003
RVEF (%) 53.2 ± 2 58.9 ± 7.2 54.8 ± 5.7 0.063 0.07 0.005
ECV 0.28 ± 0.03 0.33 ± 0.04 0.36 ± 0.03 <0.001 0.01 <0.001
LAV max index (ml/m2) 31 ± 8 50 ± 14 34 ± 9 <0.001 0.003 0.0009
LAV bac index (ml/m2) 19 ± 7 37 ± 12 30 ± 7 <0.001 0.001 0.03
LAV min index (ml/m2) 12 ± 5 20 ± 6 17 ± 4 0.009 0.009 0.22
LAPEF (%) 40 ± 9 26 ± 8 13 ± 9 <0.001 0.003 <0.0001
LACEF (%) 39 ± 5.2 46 ± 12 41 ± 9 0.26 0.18 0.3
Figure 1 Box plot of Left Atrial Passive Emptying Fraction among healthy controls, and patients with severe AS pre- and post-AVR
Graph: Left atrial passive emptying fraction (LAPEF) among healthy controls, and patients with AS, pre-and post-AVR showing a
reduction in LAPEF pre-AVR and a further decline in LAPEF at one year post-AVR.
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